STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neurons

Journal of Molecular Neuroscience

Volumn 46, Issue 1, 2012, Pages 75-87

  Holighaus, Yvonne ^a   Weihe, Eberhard ^b   Eiden, Lee E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

cAMP; ERK; PACAP; PKA; Signaling; STC1 gene induction

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ION; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; HYPOCALCIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STANNIOCALCIN 1; UNCLASSIFIED DRUG;

ARTICLE; BRAIN NERVE CELL; GENE EXPRESSION; GENE INDUCTION; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CEREBRAL CORTEX; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GLYCOPROTEINS; MAP KINASE SIGNALING SYSTEM; NEURONS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PRIMARY CELL CULTURE; RATS; RATS, WISTAR; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; TRANSCRIPTIONAL ACTIVATION;

RATTUS;

EID: 84858821460     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9653-9     Document Type: Article

References (103)

1. Ait-Ali D., Samal B., Mustafa T. and Eiden L. E. (2010) Neuropeptides, growth factors, and cytokines: a cohort of informational molecules whose expression is up-regulated by the stressassociated slow transmitter PACAP in chromaffin cells. Cell Mol Neurobiol
2. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C (1991) Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 129:2787-2789
3. Arimura A, Somogyvari-Vigh A, Weill C et al (1994) PACAP functions as a neurotrophic factor. Ann N YAcad Sci 739:228-243
4. Armstrong BD, Abad C, Chhith S et al (2008) Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide. Neuroscience 151:63-73
5. Arnsten AF, Ramos BP, Birnbaum SG, Taylor JR (2005) Protein kinase A as a therapeutic target for memory disorders: rationale and challenges. Trends Mol Med 11:121-128 (Pubitemid 40348989)
6. Baxter P. S., Martel M. A., McMahon A., Kind P. C. and Hardingham G. E. (2011) Pituitary adenylate cyclase-activating peptide induces long-lasting neuroprotection through the induction of activity-dependent signaling via the cyclic AMP response element-binding protein-regulated transcription co-activator 1. J Neurochem
7. Brenneman DE (2007) Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclaseactivating polypeptide. Peptides 28:1720-1726 (Pubitemid 47371032)
8. Cavallaro S, Copani A, D'Agata V et al (1996) Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol Pharmacol 50:60-66 (Pubitemid 26250075)
9. Chang AC, Reddel RR (1998) Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2. Mol Cell Endocrinol 141:95-99 (Pubitemid 28393383)
10. Chang AC, Janosi J, Hulsbeek M et al (1995) A novel human cDNA highly homologous to the fish hormone stanniocalcin. Mol Cell Endocrinol 112:241-247
11. Chang AC, Dunham MA, Jeffrey KJ, Reddel RR (1996) Molecular cloning and characterization of mouse stanniocalcin cDNA. Mol Cell Endocrinol 124:185-187 (Pubitemid 27042077)
12. Chang AC, Cha J, Koentgen F, Reddel RR (2005) The murine stanniocalcin 1 gene is not essential for growth and development. Mol Cell Biol 25:10604-10610 (Pubitemid 41681980)
13. Chang AC, Hook J, Lemckert FA et al (2008) The murine stanniocalcin 2 gene is a negative regulator of postnatal growth. Endocrinology 149:2403-2410 (Pubitemid 351574495)
14. Chen Y, Samal B, Hamelink CR et al (2006) Neuroprotection by endogenous and exogenous PACAP following stroke. Regul Pept 137:4-19 (Pubitemid 44751193)
15. Dautzenberg FM, Mevenkamp G, Wille S, Hauger RL (1999) Nterminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants. J Neuroendocrinol 11:941-949
16. Dejda A, Jolivel V, Bourgault S et al (2008) Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. J Mol Neurosci 36:26-37
17. Dejda A, Seaborn T, Bourgault S et al (2011) PACAP and a novel stable analog protect rat brain from ischemia: insight into the mechanisms of action. Peptides 32:1207-1216
18. Delgado M, Leceta J, Ganea D (2003) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J Leukoc Biol 73:155-164 (Pubitemid 36125686)
19. Elliott-Hunt CR, Kazlauskaite J, Wilde GJ, Grammatopoulos DK, Hillhouse EW (2002) Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. J Neurochem 80:416-425 (Pubitemid 36383025)
20. Endo K, Nakamachi T, Seki T et al (2011) Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse. J Mol Neurosci 43:22-29
21. Filvaroff EH, Guillet S, Zlot C et al (2002) Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice. Endocrinology 143:3681-3690 (Pubitemid 34925745)
22. Frechilla D, Garcia-Osta A, Palacios S, Cenarruzabeitia E, Del Rio J (2001) BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons. Neuroreport 12:919-923 (Pubitemid 32281447)
23. Ghatei MA, Takahashi K, Suzuki Y, Gardiner J, Jones PM, Bloom SR (1993) Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. J Endocrinol 136:159-166 (Pubitemid 23016124)
24. Gonzalez BJ, Basille M, Vaudry D, Fournier A, Vaudry H (1997) Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience 78:419-430 (Pubitemid 27170334)
25. Gonzalez-Zulueta M, Feldman AB, Klesse LJ et al (2000) Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci U S A 97:436-441 (Pubitemid 30055849)
26. Gottschall PE, Tatsuno I, Arimura A (1994) Regulation of interleukin- 6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res 637:197-203 (Pubitemid 24061048)
27. Grimaldi M, Cavallaro S (1999) Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes. Eur J Neurosci 11:2767-2772 (Pubitemid 29364193)
28. Grumolato L, Elkahloun AG, Ghzili H et al (2003) Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. Endocrinology 144:2368-2379 (Pubitemid 36637089)
29. Hamelink C, Lee HW, Chen Y, Grimaldi M, Eiden LE (2002a) Coincident elevation of cAMP and calcium influx by PACAP-27 synergistically regulates vasoactive intestinal polypeptide gene transcription through a novel PKA-independent signaling pathway. J Neurosci 22:5310-5320 (Pubitemid 35386452)
30. Hamelink C, Tjurmina O, Damadzic R et al (2002b) Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc Natl Acad Sci U S A 99:461-466 (Pubitemid 34060383)
31. Hannibal J (2002) Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J Comp Neurol 453:389-417
32. Harmar A. J. (2001) Family-B G-protein-coupled receptors. Genome Biol 2, REVIEWS3013
33. Harmar AJ, Arimura A, Gozes I et al (1998) International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50:265-270 (Pubitemid 28304027)
34. Hernandez A, Kimball B, Romanchuk G, Mulholland MW (1995) Pituitary adenylate cyclase-activating peptide stimulates neurite growth in PC12 cells. Peptides 16:927-932
35. Hetman M, Gozdz A (2004) Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 271:2050-2055 (Pubitemid 38747973)
36. Hetman M, Kanning K, Cavanaugh JE, Xia Z (1999) Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 274:22569-22580
37. Holighaus Y, Mustafa T, Eiden LE (2011) PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cells. Peptides 32:1647-1655
38. Irving EA, Barone FC, Reith AD, Hadingham SJ, Parsons AA (2000) Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 77:65-75 (Pubitemid 30256193)
39. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S (1992) Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-819
40. Ito D, Walker JR, Thompson CS et al (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol 24:9456-9469 (Pubitemid 39391682)
41. Jin K, Mao XO, Zhu Y, Greenberg DA (2002) MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad. J Neurochem 80:119-125 (Pubitemid 34614584)
42. Kandel ER (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294:1030-1038
43. Kienlen Campard P, Crochemore C, Rene F, Monnier D, Koch B, Loeffler JP (1997) PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway. DNA Cell Biol 16:323-333
44. Kojro E, Postina R, Buro C, Meiringer C, Gehrig-Burger K, Fahrenholz F (2006) The neuropeptide PACAP promotes the alpha-secretase pathway for processing the Alzheimer amyloid precursor protein. FASEB J 20:512-514 (Pubitemid 46671233)
45. Kuo JF, Greengard P (1969) Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3′,5′-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom. Proc Natl Acad Sci U S A 64:1349-1355
46. Lioudyno M, Skoglosa Y, Takei N, Lindholm D (1998) Pituitary adenylate cyclase-activating polypeptide (PACAP) protects dorsal root ganglion neurons from death and induces calcitonin gene-related peptide (CGRP) immunoreactivity in vitro. J Neurosci Res 51:243-256 (Pubitemid 28073032)
47. Lu N, DiCicco-Bloom E (1997) Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. Proc Natl Acad Sci U S A 94:3357-3362 (Pubitemid 27157316)
48. Lu M, Wagner GF, Renfro JL (1994) Stanniocalcin stimulates phosphate reabsorption by flounder renal proximal tubule in primary culture. Am J Physiol 267:R1356-R1362
49. Lu N, Zhou R, DiCicco-Bloom E (1998) Opposing mitogenic regulation by PACAP in sympathetic and cerebral cortical precursors correlates with differential expression of PACAP receptor (PAC1-R) isoforms. J Neurosci Res 53:651-662 (Pubitemid 28423873)
50. Luo CW, Pisarska MD, Hsueh AJ (2005) Identification of a stanniocalcin paralog, stanniocalcin-2, in fish and the paracrine actions of stanniocalcin-2 in the mammalian ovary. Endocrinology 146:469-476 (Pubitemid 40051773)
51. Lutz EM, Sheward WJ, West KM, Morrow JA, Fink G, Harmar AJ (1993) The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334:3-8
52. Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R (2006) Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Mol Cell Neurosci 31:193-209 (Pubitemid 43214530)
53. May V, Lutz E, MacKenzie C, Schutz KC, Dozark K, Braas KM (2010) Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase gamma and vesicle endocytosis for neuronal survival. J Biol Chem 285:9749-9761
54. Miyata A, Arimura A, Dahl RR et al (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574 (Pubitemid 19269770)
55. Miyata A, Jiang L, Dahl RD et al (1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170:643-648 (Pubitemid 20249468)
56. Monaghan TK, Mackenzie CJ, Plevin R, Lutz EM (2008) PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases. J Neurochem 104:74-88 (Pubitemid 350265065)
57. Morio H, Tatsuno I, Hirai A, Tamura Y, Saito Y (1996) Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity. Brain Res 741:82-88 (Pubitemid 26426301)
58. Nicot A, DiCicco-Bloom E (2001) Regulation of neuroblast mitosis is determined by PACAP receptor isoform expression. Proc Natl Acad Sci U S A 98:4758-4763 (Pubitemid 32295049)
59. Nogi H, Hashimoto H, Fujita T, Hagihara N, Matsuda T, Baba A (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP) receptor mRNA in the rat adrenal gland: localization by in situ hybridization and identification of splice variants. Jpn J Pharmacol 75:203-207 (Pubitemid 27491558)
60. Nowak JZ, Jozwiak-Bebenista M, Bednarek K (2007) Effects of PACAP and VIP on cyclic AMP formation in rat neuronal and astrocyte cultures under normoxic and hypoxic condition. Peptides 28:1706-1712 (Pubitemid 47361419)
61. Ohtaki H, Nakamachi T, Dohi K et al (2006) Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc Natl Acad Sci U S A 103:7488-7493 (Pubitemid 43727860)
62. Ohtaki H, Nakamachi T, Dohi K, Shioda S (2008) Role of PACAP in ischemic neural death. J Mol Neurosci 36:16-25
63. Onoue S, Endo K, Ohshima K, Yajima T, Kashimoto K (2002a) The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells. Peptides 23:1471-1478 (Pubitemid 35223015)
64. Onoue S, Endo K, Yajima T, Kashimoto K (2002b) Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide attenuate glutamate-induced nNOS activation and cytotoxicity. Regul Pept 107:43-47 (Pubitemid 34876444)
65. Pantaloni C, Brabet P, Bilanges B et al (1996) Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem 271:22146-22151 (Pubitemid 26303846)
66. Pellegri G, Magistretti PJ, Martin JL (1998) VIP and PACAP potentiate the action of glutamate on BDNF expression in mouse cortical neurones. Eur J Neurosci 10:272-280 (Pubitemid 28325449)
67. Pisegna JR, Wank SA (1993) Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc Natl Acad Sci U S A 90:6345-6349 (Pubitemid 23191512)
68. Pisegna JR, Wank SA (1996) Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C. J Biol Chem 271:17267-17274 (Pubitemid 26244284)
69. Pugh PC, Margiotta JF (2006) PACAP support of neuronal survival requires MAPK- and activity-generated signals. Mol Cell Neurosci 31:586-595 (Pubitemid 43358029)
70. Rat D., Schmitt U., Tippmann F., et al. (2011) Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor proteintransgenic mice. FASEB J
71. Ravni A, Vaudry D, Gerdin MJ et al (2008) A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells. Mol Pharmacol 73:1688-1708 (Pubitemid 351724358)
72. Reglodi D, Somogyvari-Vigh A, Vigh S, Kozicz T, Arimura A (2000) Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke 31:1411-1417 (Pubitemid 30351265)
73. Reglodi D, Tamas A, Somogyvari-Vigh A et al (2002) Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides 23:2227-2234 (Pubitemid 36092058)
74. Reglodi D, Lubics A, Tamas A, Szalontay L, Lengvari I (2004) Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease. Behav Brain Res 151:303-312 (Pubitemid 38501453)
75. Reglodi D, Lubics A, Kiss P et al (2006) Effect of PACAP in 6- OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats. Neuropeptides 40:265-274 (Pubitemid 44308347)
76. Said SI, Dickman K, Dey RD et al (1998) Glutamate toxicity in the lung and neuronal cells: prevention or attenuation by VIP and PACAP. Ann N Y Acad Sci 865:226-237 (Pubitemid 29047831)
77. Shintani N, Suetake S, Hashimoto H et al (2005) Neuroprotective action of endogenous PACAP in cultured rat cortical neurons. Regul Pept 126:123-128 (Pubitemid 40037754)
78. Shioda S, Ohtaki H, Nakamachi T et al (2006) Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment. Ann N Y Acad Sci 1070:550-560 (Pubitemid 44126702)
79. Shoge K, Mishima HK, Saitoh T et al (1999) Attenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neurons. Brain Res 839:66-73 (Pubitemid 29389794)
80. Spengler D, Waeber C, Pantaloni C et al (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-175 (Pubitemid 23282064)
81. Stetler RA, Gao Y, Zukin RS et al (2010) Apurinic/apyrimidinic endonuclease APE1 is required for PACAP-induced neuroprotection against global cerebral ischemia. Proc Natl Acad Sci U S A 107:3204-3209
82. Stumm R, Kolodziej A, Prinz V, Endres M, Wu DF, Hollt V (2007) Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage. J Neurochem 103:1666-1681 (Pubitemid 47631830)
83. Sundler F, Ekblad E, Hannibal J et al (1996) Pituitary adenylate cyclase-activating peptide in sensory and autonomic ganglia: localization and regulation. Ann N Y Acad Sci 805:410-426, discussion 427-418
84. Tabuchi A, Funaji K, Nakatsubo J, Fukuchi M, Tsuchiya T, Tsuda M (2003) Inactivation of aconitase during the apoptosis of mouse cerebellar granule neurons induced by a deprivation of membrane depolarization. J Neurosci Res 71:504-515 (Pubitemid 36158334)
85. Tamas A, Reglodi D, Szanto Z, Borsiczky B, Nemeth J, Lengvari I (2002) Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats. Neuro Endocrinol Lett 23:249-254 (Pubitemid 34741935)
86. Tanaka J, Koshimura K, Murakami Y, Sohmiya M, Yanaihara N, Kato Y (1997) Neuronal protection from apoptosis by pituitary adenylate cyclase-activating polypeptide. Regul Pept 72:1-8 (Pubitemid 27492057)
87. Tatsuno I, Morio H, Tanaka T et al (1996) Pituitary adenylate cyclaseactivating polypeptide (PACAP) is a regulator of astrocytes: PACAP stimulates proliferation and production of interleukin 6 (IL-6), but not nerve growth factor (NGF), in cultured rat astrocyte. Ann N Y Acad Sci 805:482-488 (Pubitemid 27058045)
88. Tomimatsu N, Arakawa Y (2008) Survival-promoting activity of pituitary adenylate cyclase-activating polypeptide in the presence of phosphodiesterase inhibitors on rat motoneurons in culture: cAMP-protein kinase A-mediated survival. J Neurochem 107:628-635
89. Varghese R, Gagliardi AD, Bialek PE, Yee SP, Wagner GF, Dimattia GE (2002) Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice. Endocrinology 143:868-876 (Pubitemid 34164035)
90. Vaudry D, Gonzalez BJ, Basille M, Anouar Y, Fournier A, Vaudry H (1998) Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience 84:801-812 (Pubitemid 28137896)
91. Vaudry D, Gonzalez BJ, Basille M et al (2000) The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Proc Natl Acad Sci U S A 97:13390-13395
92. Vaudry D, Pamantung TF, Basille M et al (2002a) PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur J Neurosci 15:1451-1460 (Pubitemid 35477975)
93. Vaudry D, Rousselle C, Basille M et al (2002b) Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc Natl Acad Sci U S A 99:6398-6403 (Pubitemid 34493323)
94. Villalba M, Bockaert J, Journot L (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogenactivated protein kinase (MAP kinase) pathway. J Neurosci 17:83-90 (Pubitemid 27008852)
95. Wagner GF, Hampong M, Park CM, Copp DH (1986) Purification, characterization, and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of Stannius. Gen Comp Endocrinol 63:481-491 (Pubitemid 16043798)
96. Wagner GF, Gellersen B, Friesen HG (1989) Primary culture of teleocalcin cells from rainbow trout corpuscles of Stannius: regulation of teleocalcin secretion by calcium. Mol Cell Endocrinol 62:31-39 (Pubitemid 19070491)
97. Waschek JA (2002) Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Dev Neurosci 24:14-23
98. Westberg JA, Serlachius M, Lankila P, Andersson LC (2007a) Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart. Am J Physiol Heart Circ Physiol 293:H1766-H1771 (Pubitemid 47367226)
99. Westberg JA, Serlachius M, Lankila P, Penkowa M, Hidalgo J, Andersson LC (2007b) Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling. Stroke 38:1025-1030 (Pubitemid 46568469)
100. Zeiger W., Ito D., Swetlik C., Oh-Hora M., Villereal M. L. and Thinakaran G. (2011) Stanniocalcin 2 is a negative modulator of store-operated calcium entry. Mol Cell Biol
101. Zhang KZ, Westberg JA, Paetau A et al (1998) High expression of stanniocalcin in differentiated brain neurons. Am J Pathol 153:439-445 (Pubitemid 28373655)
102. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC (2000) Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci U S A 97:3637-3642 (Pubitemid 30183355)
103. Zhou CJ, Kikuyama S, Shibanuma M et al (2000) Cellular distribution of the splice variants of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC(1)-R) in the rat brain by in situ RT-PCR. Brain Res Mol Brain Res 75:150-158 (Pubitemid 30058337)